These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17543724)

  • 1. Why men's hearts break: cardiovascular effects of sex steroids.
    Choi BG; McLaughlin MA
    Endocrinol Metab Clin North Am; 2007 Jun; 36(2):365-77. PubMed ID: 17543724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone and coronary artery disease in men.
    Webb CM; Collins P
    Maturitas; 2010 Sep; 67(1):15-9. PubMed ID: 20447781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
    Ren J; Kelley RO
    Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of coronary artery disease in men: male hormone, female hormone, or both?
    Yang C; Wang X; Geng C; Ding H
    Med Hypotheses; 2010 Dec; 75(6):671-3. PubMed ID: 20810222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex steroids and endothelial function: translating basic science to clinical practice.
    Miller VM; Mulvagh SL
    Trends Pharmacol Sci; 2007 Jun; 28(6):263-70. PubMed ID: 17466385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences and the effects of sex hormones on hemostasis and vascular reactivity.
    Schwertz DW; Penckofer S
    Heart Lung; 2001; 30(6):401-26; quiz 427-8. PubMed ID: 11723446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women with coronary artery disease and depression: a neglected risk group.
    Möller-Leimkühler AM
    World J Biol Psychiatry; 2008; 9(2):92-101. PubMed ID: 17853281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex steroid-induced changes in circulating monocyte chemoattractant protein-1 levels may contribute to metabolic dysfunction in obese men.
    Ruige JB; Bekaert M; Lapauw B; Fiers T; Lehr S; Hartwig S; Herzfeld de Wiza D; Schiller M; Passlack W; Van Nieuwenhove Y; Pattyn P; Cuvelier C; Taes YE; Sell H; Eckel J; Kaufman JM; Ouwens DM
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1187-91. PubMed ID: 22523336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concentrations of adrenal steroids and sex hormones in postmenopausal women suffering from coronary artery disease].
    Sablik Z; Samborska-Sablik A; Goch JH
    Pol Merkur Lekarski; 2008 Oct; 25(148):326-9. PubMed ID: 19145930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links.
    Vlachopoulos C; Rokkas K; Ioakeimidis N; Stefanadis C
    Eur Urol; 2007 Dec; 52(6):1590-600. PubMed ID: 17707576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of endothelin-1 release from human endothelial cells by sex steroids and angiotensin-II.
    Pearson LJ; Yandle TG; Nicholls MG; Evans JJ
    Peptides; 2008 Jun; 29(6):1057-61. PubMed ID: 18378042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function.
    Klaus JR; Hurwitz BE; Llabre MM; Skyler JS; Goldberg RB; Marks JB; Bilsker MS; Schneiderman N
    J Cardiometab Syndr; 2009; 4(2):63-71. PubMed ID: 19614791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of chronic exogenous androgen on myocardial function following acute ischemia-reperfusion in hosts with different baseline levels of sex steroids.
    Nam UH; Wang M; Crisostomo PR; Markel TA; Lahm T; Meldrum KK; Lillemoe KD; Meldrum DR
    J Surg Res; 2007 Sep; 142(1):113-8. PubMed ID: 17597161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular and metabolic effects of sex steroids: new insights into clinical trials.
    Wierman ME; Kohrt WM
    Reprod Sci; 2007 May; 14(4):300-14. PubMed ID: 17644802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial function and inflammation in coronary artery disease.
    Tousoulis D; Charakida M; Stefanadis C
    Postgrad Med J; 2008 Jul; 84(993):368-71. PubMed ID: 18716016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of coronary dysfunction in obesity and insulin resistance.
    Knudson JD; Dincer UD; Bratz IN; Sturek M; Dick GM; Tune JD
    Microcirculation; 2007; 14(4-5):317-38. PubMed ID: 17613805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different roles of sex steroid hormones in the pathogenesis of vascular dysfunction and the development of cardiovascular disease in men and women.
    Atalić B; Unfirer S; Kibel A; Drenjancević-Perić I
    Coll Antropol; 2009 Jun; 33(2):673-80. PubMed ID: 19662797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male hypogonadism: The unrecognized cardiovascular risk factor.
    Potenza M; Shimshi M
    J Clin Lipidol; 2008 Apr; 2(2):71-8. PubMed ID: 21291723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.